A Phase I Study Of The Pi3k Inhibitor Buplarlisib (B) With Concurrent Chemoradiotherapy (Crt) In Patients With High Risk Locally Advanced Squamous Cell Cancer Of The Head And Neck (Lascchn)

JOURNAL OF CLINICAL ONCOLOGY(2018)

引用 4|浏览20
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要